Production and Screening Hits - Drug Discovery Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Production

Screening Hits

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

We Need Better Benchmarks for Machine Learning in Drug Discovery

Practical Cheminformatics

AUGUST 3, 2023

It is quite a bit more potent than the values one finds with screening hits, which typically have IC50s in the single to double-digit µM range. Molecules with IC50 values less than 200nM are considered active, and molecules with IC50 values greater than or equal to 200nM are considered inactive.

Drugs

Drugs Biochemical Assays Metabolic Stability Screening Hits

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Target-directed cancer: protein-ligand interactions

We Need Better Benchmarks for Machine Learning in Drug Discovery

Webinars

Stay Connected